Clinical trial
Phase 1 Open Label Study of Zinc Therapy in ALS Patients
NCT01259050 is registered in ClinicalTrials.gov with Phoenix Neurological Associates, LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Open Label Study of Zinc Therapy in ALS Patients
- Lead sponsor
- Phoenix Neurological Associates, LTD
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- March 31, 2012
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.